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Introduction

27
The discharge of pharmaceuticals in wastewater into the aquatic environment has been a source of 28 concern in scientific circles for more than a decade (Daughton and Ternes, 1999; Verlicchi et al., 2012) and is 29 now appearing on the agenda of European legislators. This was highlighted by a proposal from the European 30
• To compare the range of predicted concentrations in effluents with those reported in the literature, 81
• To predict surface water concentrations throughout Europe using a spatially explicit model, 82
• To compare national predicted river concentrations against published measured concentrations 83
• To examine whether current predicted concentrations might exceed those which are acutely toxic to 84 algae, the most sensitive aquatic species? 85
Methods 86
Method introduction 87
The process begins with collecting information on national consumption which is converted to a per 88 capita rate. Then information is gathered on excretion rates of the parent compound followed by a review 89 of removal rates of the parent compound in sewage treatment. This information can be used to predict 90 effluent concentrations for different countries using assumptions on wastewater discharge per capita. The 91 research involved using ranges of key words on popular academic search engines to acquire literature and 92 then examining the references in that literature to widen the net. Peer-reviewed data were preferred, 93 unless these were absent or excellent quality publicly available information was present. This does not 94 guarantee all the best literature is found, nevertheless the assumptions and consequent rates can be tested 95 against measured values. To predict concentrations in real river water situations, the rate information can 96 be imported into GIS-based water quality models. The model will associate the population connected to 97 sewage treatment plants with the pharmaceutical consumption/excretion and sewage removal information 98 previously collected in actual river networks. 99
Assessing per capita consumption rates 100
The first and arguably most important hurdle to overcome in any predictive model aiming to report 101 concentrations of human derived pharmaceuticals in water is obtaining accurate information on 102 consumption (Johnson et al., 2008) . If this is incorrect the modelling exercise will fail before it has begun. 103
Reports in the literature can be used to assess a per capita consumption, given the population of the country 104 at that time (Table 1) . The consumption data found ranged from as recent as four years to sixteen years ago. 105
However, overall changes in European national antibiotic consumption over time tend to be small as 106 revealed in a survey of use for 1997-2009. For example, over this period there was a 2% increase in the UK, 107 an 8% drop in Spain and a 14% increase in Germany (Adriaenssens et al., 2011) . 108 109 Table 1 National antibiotic drug consumption data (mg/cap/d) collected for ciproflaxacin (CIP), Sulfamethoxazole (SUF), trimethoprim (TRI) and erthromycin (ERY). The data, originally in g/year, was transformed to mg/cap/day using the national population* 1 at the time of the survey. can influence pharmaceutical removal rates in treatment. Information on the proportion of these drugs 125 excreted as parent compounds was limited for CIP but more abundant for the other compounds (Table S1) . 126
Country
The biggest variations in excretion were associated with ERY (Table S1 ). There is a large amount of 127 information on how much of these drugs is removed in sewage treatment but the data can vary 128 considerably, for example, ERY removal data ranged from 0 to79% (Table S2) . 129 Table 2 Summary of loss rates used in the modelling for the antibiotics following receipt of national consumption rates. Expected is the median whilst best and worst are the extremes reported in the literature 
Losses
130
So the effluent concentrations are predicted by taking the drug consumption per capita for a specific nation 131 less that prevented from being excreted as the free parent compound less that removed in sewage 132 treatment. The effluent concentration (W, in ng/L) is derived as follows for a specific nation: 133
Where C is the substance consumption (ng/cap/d); E is the substance amount not excreted (ng/cap/d); R is 135 the amount of the drug that is prevented from escaping into sewage effluent (ng/cap/d); and D is the 136 volume of wastewater ( L/cap/d). 137
Scenario analysis 138
There are uncertainties in the model parameters determining effluent concentrations. Firstly, drug 139 popularity can wax and wane from year to year, and there will be some seasonal trends. Where a national 140 consumption was not known a European average was used. Then there are the uncertainties regarding the 141 amount excreted (Table S1 ) and removed in sewage treatment (Table S2 and 2). In order to encompass the 142 range of these variables, a series of scenarios were run to cover likely effluent and river concentrations 143 based on the diverging literature values. These scenarios were a best case (low excretion, high sewage 144 removal); a worst case (high excretion, low removal) and an expected case, which used the average values 145 for these parameters. Thus, the best to worst case should encompass the range of possible effluent and 146 river concentrations (Table 2) . Seasonal use variation would be difficult to add to the scenarios because 147 different antibiotics might be more, or less, popular in different seasons, which could vary between different 148 countries. 149
When comparing the predicted effluent concentrations calculated using the values from Tables 2, S1  150 and S2 with those reported in the literature for different nations, the expected or best case predictions were 151 frequently closest to reported values (Table 3) . Thus, it might be expected that using the worst case scenario 152 would overestimate river concentrations. 153 Table 3 Comparing expected, worst and best case predicted to measured effluent concentrations for ciproflaxacin (CIP), sulfamethoxazole (SUF), trimethoprim (TRI) and erythromycin (ERY). 
European river water modelling 158
To estimate concentrations of these antibiotics throughout European surface waters, the spatially-159 explicit water resources model GWAVA was used in a water quality mode (Dumont et based on the 31 year monthly climate dataset and taking into account the upstream input. GWAVA can also 170 modify the concentrations along the river network by including a water column biodegradation rate. 171
However, in this case the antibiotics were assumed to be conservative once in the river due to limited 172 biodegradation rate information. This assumption that the antibiotics will be conserved in the rivers means 173 the predictions will be precautionary (a bias towards overestimation). Nitrogen (Table 4) . 187
188
Table 4
Summary of the variables and their potential effects on the estimated effluent concentrations for ciproflaxacin (CIP), sulfamethoxazole (SUF), trimethoprim (TRI) and erthromycin (ERY). 
Drug
Predicted European river antibiotic river concentrations 190
The distribution of concentrations around Europe is dependent not just on the local geography and 191 hydrology but also on the national drug consumption. The spatial variation in surface water concentrations 192 can be seen in annual average maps for TRI and SUF (Figs. 1 and 2) The complete range of concentrations predicted in the model across Europe can be shown using cumulative 207 frequency curves (Fig 3 and 4) and compared against the lowest reported effect levels for wildlife (Table 5) (Fig. 3) . It should be clarified that each cell 212 generates 372 results per simulation (based on the 31 years of monthly climate data) and from these a 213 mean, median or percentile can be selected. For the worst case scenario (high excretion and poor removal) 214 and taking the 90%ile for each cell estimated concentrations could reach between 0.1 and 1 µg/L in the most 215 exposed river length for all 4 antibiotics (Fig 4) . 216
Comparing predicted and measured river antibiotic concentrations 217
Antibiotics monitored in European rivers fall within the predicted range of concentrations by the 218 modelling (Table 5 and 
The potential for widespread toxicity from antibiotics in European rivers 238
These four antibiotics appear to have little or no toxicity to fish or Daphnia species (Table 5) . But 239 harmful effects can be seen with the duck weed group which appear to be the most sensitive organisms to 240 SUF. The most sensitive species for the other antibiotics seem to be cyanobacteria followed by green algae 241 with effects observed in the tens of µg/L. Fortunately, it would seem that the antibiotic concentrations 242 measured in regular domestic effluent were all below the median effect levels of the most sensitive species. 243
This indicates that these antibiotics at current levels of consumption are not posing a widespread acute toxic 244 threat to European aquatic wildlife. The CIP and ERY predicted and observed river concentrations appear to 245 be closest to the EC50 levels but still 2 orders of magnitude lower. Trimethoprim appears to be of the least 246 concern, with concentrations predicted to be around 6 orders of magnitude below algal effect levels 247 followed by SUF with 3 orders of magnitude difference. We cannot comment on to what extent such river 248 concentrations might stimulate antibiotic resistance. 249 Table 5 Comparison of harmful effect concentrations for freshwater organisms reported in the literature for ciprofloxacin, sulfamethoxazole, trimethoprim and erythromycin against predicted and observed and river concentrations example that analytical chemists would be much more likely to find TRI in German effluents and rivers than 261 in Spanish ones since consumption is apparently 100-fold higher. Given that predicted CIP and ERY antibiotic 262 river concentrations were only 2-fold below known effect levels for algae, this study endorses the listing of 263 these antibiotics as pharmaceuticals of concern in reviews on the topic ( seems unlikely that these antibiotics, which have been identified as amongst those of the greatest concern, 266 are actually causing significant acute toxicity problems today for wildlife on their own. But, there may be a 267 case for mixture effects leading to a higher net concern for the antibiotics (Backhaus and Karlsson, 2014) . 268
The question of the promulgation of environmental antibiotic resistance was not addressed in this study, but 269 the presence of hundreds of ng/L of some antibiotics in high exposure hotspots in European rivers should be 270 noted. 271
Conflicts of interest 272
I certify that there is no conflict of interest with any organisation regarding the material discussed in 273 this manuscript 274 This reference also gives intra venous excretion rates. However, in the UK the IV route for antibiotics is 532 typically less than 1% of the total and so the higher excretion from this route was not considered important. 533 
